N-of-1 Trials

Patient and clinician reviewing repeated symptom measurements for a single-person trial

N-of-1 Trials Explainer

An N-of-1 trial is a structured experiment designed to compare treatments within one participant. The person receives interventions in multiple time periods, often in a randomized sequence, while outcomes are measured repeatedly. The aim is to learn which option works better for that individual, not simply to describe what happened after trying one treatment. Repeated switching and standardized measurement distinguish the design from an informal trial-and-error story.

A typical plan compares treatment A with treatment B or placebo across several blocks. Blinding can reduce expectation effects, and washout periods can limit carryover. The outcome should matter to the participant and change soon enough to measure during each period. The condition should be reasonably stable, and the treatments should have effects that begin and end predictably rather than permanently altering the disease.

N-of-1 trials are not suitable for emergencies, cures, preventive treatments whose outcomes take years, or interventions with lasting effects. Day-to-day symptom variation, adherence, incomplete blinding, and too few treatment periods can mislead. A result from one participant also does not automatically apply to other people. Several similarly designed N-of-1 trials may be combined for broader estimates, but that is a separate analysis.

The design can be useful when average trial results do not answer which of two reasonable options helps a particular person. It turns personal treatment selection into a prospective plan with defined outcomes instead of relying on memory. Conduct should remain clinically supervised, ethical, and feasible. The strength of the conclusion depends on randomization, repeated observations, adequate periods, and an outcome that truly responds to the treatments being compared.

The same person cycles through treatments in a planned sequence while outcomes are measured repeatedly.

That structure provides more information than trying one option and relying on memory.

N-of-1 trials suit stable conditions and treatments with prompt, reversible effects.

The chosen outcome should be meaningful to the participant and measurable during each period.

A well-run trial may clarify what works for one participant.

Its result cannot automatically be generalized to everyone with the same diagnosis.

Explore more "Explainers"

Discover additional explainers across politics, science, business, technology, and other fields. Each explainer breaks down a complex idea into clear, everyday language—helping you better understand how major concepts, systems, and debates shape the world around us.